These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33755690)

  • 1. Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms.
    Karman J; Wang J; Bodea C; Cao S; Levesque MC
    PLoS One; 2021; 16(3):e0248889. PubMed ID: 33755690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
    Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
    J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis.
    Wang Y; Yella JK; Ghandikota S; Cherukuri TC; Ediga HH; Madala SK; Jegga AG
    Ther Adv Respir Dis; 2020; 14():1753466620971143. PubMed ID: 33167785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.
    Zhang Y; Jones KD; Achtar-Zadeh N; Green G; Kukreja J; Xu B; Wolters PJ
    Histopathology; 2019 Jan; 74(2):341-349. PubMed ID: 30152895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis.
    Zhao T; Wu X; Zhao X; Yao K; Li X; Ni J
    Front Immunol; 2023; 14():1159856. PubMed ID: 37122736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
    Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
    Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)-Approaching with Next-Generation Sequencing and Bioinformatics.
    Chang WA; Chen CM; Sheu CC; Liao SH; Hsu YL; Tsai MJ; Kuo PL
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IPF-related new macrophage subpopulations and diagnostic biomarker identification - combine machine learning with single-cell analysis.
    Zhang H; Yang Y; Cao Y; Guan J
    Respir Res; 2024 Jun; 25(1):241. PubMed ID: 38872139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
    DePianto DJ; Chandriani S; Abbas AR; Jia G; N'Diaye EN; Caplazi P; Kauder SE; Biswas S; Karnik SK; Ha C; Modrusan Z; Matthay MA; Kukreja J; Collard HR; Egen JG; Wolters PJ; Arron JR
    Thorax; 2015 Jan; 70(1):48-56. PubMed ID: 25217476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.
    Bahudhanapati H; Tan J; Dutta JA; Strock SB; Sembrat J; Àlvarez D; Rojas M; Jäger B; Prasse A; Zhang Y; Kass DJ
    J Biol Chem; 2019 Mar; 294(13):5008-5022. PubMed ID: 30709904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
    Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle.
    Meltzer EB; Barry WT; D'Amico TA; Davis RD; Lin SS; Onaitis MW; Morrison LD; Sporn TA; Steele MP; Noble PW
    BMC Med Genomics; 2011 Oct; 4():70. PubMed ID: 21974901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
    Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
    Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.
    Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M
    Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype.
    Fraser E; Denney L; Antanaviciute A; Blirando K; Vuppusetty C; Zheng Y; Repapi E; Iotchkova V; Taylor S; Ashley N; St Noble V; Benamore R; Hoyles R; Clelland C; Rastrick JMD; Hardman CS; Alham NK; Rigby RE; Simmons A; Rehwinkel J; Ho LP
    Front Immunol; 2021; 12():623430. PubMed ID: 33746960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating cellular experiments, single-cell sequencing, and machine learning to identify endoplasmic reticulum stress biomarkers in idiopathic pulmonary fibrosis.
    Liao Y; Peng X; Yang Y; Zhou G; Chen L; Yang Y; Li H; Chen X; Guo S; Zuo Q; Zou J
    Ann Med; 2024 Dec; 56(1):2409352. PubMed ID: 39340293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis.
    Kim SK; Jung SM; Park KS; Kim KJ
    BMC Pulm Med; 2021 Dec; 21(1):404. PubMed ID: 34876074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior.
    Munguía-Reyes A; Balderas-Martínez YI; Becerril C; Checa M; Ramírez R; Ortiz B; Meléndez-Zajgla J; Pardo A; Selman M
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):65-76. PubMed ID: 29345973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.
    Yu W; Guo F; Song X
    Pharm Biol; 2017 Dec; 55(1):450-455. PubMed ID: 27937011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.